CD20-CD19 Compound CAR (cCAR) T Cells for Patients With Relapsed /Refractory B Cell Malignancies
Clinical trial NCT04156178 · UNKNOWN
Trial details
- NCT number
- NCT04156178
- Sponsor
- iCell Gene Therapeutics
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2020-09-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.